Qube Research & Technologies LTD Ars Pharmaceuticals, Inc. Comm Transaction History

Qube Research & Technologies LTD

  • $65.7 Billion
  • Q3 2024

A detailed history of Qube Research & Technologies LTD transactions in Ars Pharmaceuticals, Inc. Comm stock. As of the latest transaction made, Qube Research & Technologies LTD holds 39,696 shares of SPRY stock, worth $0. This represents 0.0% of its overall portfolio holdings.

Number of Shares
39,696
Holding current value
$0
% of portfolio
0.0%

Shares

8 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024
BUY
N/A
39,696 New
39,696 $0
Q1 2024

May 14, 2024
BUY
N/A
12,633 New
12,633 $0
Q1 2023

May 15, 2023
BUY
N/A
48,532 Added 168.3%
77,369 $0
Q4 2022

Feb 14, 2023
BUY
N/A
12,412 Added 75.57%
28,837 $0
Q3 2022

Nov 14, 2022
SELL
N/A
-1,441 Reduced 8.07%
16,425 $87,000
Q2 2022

Aug 15, 2022
BUY
N/A
17,866 New
17,866 $76,000
Q1 2021

May 14, 2021
SELL
N/A
-19,484 Closed
0 $0
Q4 2020

Feb 16, 2021
BUY
N/A
19,484 New
19,484 $903,000

About ARS PHARMACEUTICALS, INC. COMM

SPRY Quotes by TradingView
  • Ticker SPRY
More about SPRY
Track This Portfolio

Track Qube Research & Technologies LTD Portfolio

Follow Qube Research & Technologies LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

News

Stay updated on Qube Research & Technologies LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email